These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 18945270)
1. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure. Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts. Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521 [TBL] [Abstract][Full Text] [Related]
3. Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics. Rentsch KM; Kullak-Ublick GA; Reichel C; Meier PJ; Fattinger K Clin Pharmacol Ther; 2001 Sep; 70(3):237-46. PubMed ID: 11557911 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Rook EJ; van Ree JM; van den Brink W; Hillebrand MJ; Huitema AD; Hendriks VM; Beijnen JH Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):86-96. PubMed ID: 16433897 [TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Darwish M; Tempero K; Kirby M; Thompson J Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093 [TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine. Kharasch ED; Hoffer C; Whittington D; Sheffels P Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457 [TBL] [Abstract][Full Text] [Related]
7. Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets. Perger L; Rentsch KM; Kullak-Ublick GA; Verotta D; Fattinger K Eur J Pharm Sci; 2009 Mar; 36(4-5):421-32. PubMed ID: 19084595 [TBL] [Abstract][Full Text] [Related]
8. Morphine and 6-acetylmorphine concentrations in blood, brain, spinal cord, bone marrow and bone after lethal acute or chronic diacetylmorphine administration to mice. Guillot E; de Mazancourt P; Durigon M; Alvarez JC Forensic Sci Int; 2007 Mar; 166(2-3):139-44. PubMed ID: 16730149 [TBL] [Abstract][Full Text] [Related]
9. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. Klous MG; Van den Brink W; Van Ree JM; Beijnen JH Drug Alcohol Depend; 2005 Dec; 80(3):283-95. PubMed ID: 15916865 [TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study on orally administered heroin substitution for severely addicted opioid users. Frick U; Rehm J; Kovacic S; Ammann J; Uchtenhagen A Addiction; 2006 Nov; 101(11):1631-9. PubMed ID: 17034443 [TBL] [Abstract][Full Text] [Related]
11. Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. Rook EJ; van Zanten AP; Van den Brink W; van Ree JM; Beijnen JH Drug Alcohol Depend; 2006 Dec; 85(3):185-90. PubMed ID: 16765536 [TBL] [Abstract][Full Text] [Related]
12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs. Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting. Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine. Zandvliet AS; Huitema AD; de Jonge ME; den Hoed R; Sparidans RW; Hendriks VM; van den Brink W; van Ree JM; Beijnen JH Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):71-9. PubMed ID: 15667599 [TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations. Dohoo SE; Tasker RA Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447 [TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]